SUMMARY The hospital setting introduces a number of challenges to implementing this type of intervention, including recruitment barriers and high attrition rates. Patient engagement in smoking cessation is likely to be affected by the reason for admission and patients' stage of change To be successful, smoking cessation interventions may need to be tailored to the patients' degree of motivation, as evidenced by their stage of change
Key WordsSmoking cessation; interventions; photoageing
ABSTRACT BackgroundYoung adults are reluctant to use evidence-based smoking cessation interventions. Subsequently, they are less successful at giving up smoking compared to older adults. This highlights the need for innovative strategies to engage young people in smoking cessation. A novel intervention using photoageing technology has been shown to be an effective trigger for smoking cessation.
AimsTo conduct a pilot study deploying photoageing technology to trigger smoking cessation attempts in young adults admitted to hospital.
MethodA randomised controlled trial was designed. Thirty participants were recruited from a regional hospital in Melbourne, Australia. Participants were allocated to the intervention and control groups on alternate weeks. All participants received brief smoking cessation advice. The intervention group was digitally aged using the APRIL Face Aging Software. The primary outcomes were measured at six weeks' post-intervention and included number of quit attempts, nicotine dependence, and progression through the stages of change model.
ResultsAt six weeks' post-intervention, there was no difference in quit attempts between the two groups (Mann-Whitney U=111 and p=0.484). There was also no difference in nicotine dependence (Mann-Whitney U=106 and p=0.403) or stage of change ( 2 =1.71 and p=0.634) between the groups.
ConclusionHospitalisation is associated with a number of barriers, which prevent the implementation of photoageing technology in this setting. Of these barriers, participant recruitment and retention pose the greatest challenge. Due to these considerations, it was not possible to demonstrate an effect size with any confidence.
BACKGROUNDCigarette smoke is the leading cause of preventable death and disease in Australia.